Antihypertensive therapy debate: Contribution from the Shanghai Trial Of Nifedipine in the Elderly (STONE)

Journal of Hypertension, Supplement

Volumn 14, Issue 4, 1996, Pages

  Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Calcium channel blockers; Hypertension; Nifedipine; Stroke; Trials

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0030473431     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Zanchetti A, Chalmers J, Arakawa K, Gyarias I, Hamet P, Hansson L, et al.: Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993, 11:905-918.
2. Joint National Committee: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993, 153:154-183.
3. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al.: Management guidelines in essential hypertension: report of the Second Working Party of the British Hypertension Society. BMJ 1993, 306:983-987.